Literature DB >> 7578366

Vitamin B12 mediated oral delivery systems for granulocyte-colony stimulating factor and erythropoietin.

G J Russell-Jones1, S W Westwood, A D Habberfield.   

Abstract

As a prelude to the development of orally active erythropoietin (EPO) and granulocyte-colony stimulating factor (G-CSF), conjugates have been formed between these molecules and vitamin B12. During the formation of these conjugates intramolecular cross-linking of the proteins was avoided by the use of hydrazidyl derivatives of vitamin B12. A potentially biodegradable linkage was formed between vitamin B12 and G-CSF by reaction of the buried thiol in G-CSF with a long chain dithiopyridyl derivative of vitamin B12. In vitro and in vivo testing of the conjugates showed that their bioactivity was substantially maintained and that they were actively transported in an intrinsic factor dependent fashion across CaCo-2 cells and from the intestine to the circulation in a biologically active form.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7578366     DOI: 10.1021/bc00034a016

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  11 in total

Review 1.  Recent advances in intestinal macromolecular drug delivery via receptor-mediated transport pathways.

Authors:  P W Swaan
Journal:  Pharm Res       Date:  1998-06       Impact factor: 4.200

Review 2.  Chemically modified peptides and proteins - critical considerations for oral delivery.

Authors:  Stephen T Buckley; František Hubálek; Ulrik Lytt Rahbek
Journal:  Tissue Barriers       Date:  2016-03-03

3.  Adaptive regulation of riboflavin transport in heart: effect of dietary riboflavin deficiency in cardiovascular pathogenesis.

Authors:  Tamilarasan Udhayabanu; Sellamuthu Karthi; Ayyavu Mahesh; Perumal Varalakshmi; Andreea Manole; Henry Houlden; Balasubramaniem Ashokkumar
Journal:  Mol Cell Biochem       Date:  2017-08-23       Impact factor: 3.396

4.  Evaluation of bioadhesive capacity and immunoadjuvant properties of vitamin B(12)-Gantrez nanoparticles.

Authors:  Hesham H Salman; Carlos Gamazo; P Chris de Smidt; Gregory Russell-Jones; Juan M Irache
Journal:  Pharm Res       Date:  2008-08-05       Impact factor: 4.200

5.  Protoporphyrin IX/Cobyrinate Derived Hybrids - Novel Activators of Soluble Guanylyl Cyclase.

Authors:  Mikołaj Chromiński; Keith Ó Proinsias; Emil Martin; Dorota Gryko
Journal:  European J Org Chem       Date:  2013-01-28

6.  Investigation Of Vitamin B12-Modified Amphiphilic Sodium Alginate Derivatives For Enhancing The Oral Delivery Efficacy Of Peptide Drugs.

Authors:  Lingli Long; Minghua Lai; Xuhong Mao; Jiahao Luo; Xin Yuan; Li-Ming Zhang; Zunfu Ke; Liqun Yang; David Yb Deng
Journal:  Int J Nanomedicine       Date:  2019-09-20

7.  Vitamin B12 conjugation of peptide-YY(3-36) decreases food intake compared to native peptide-YY(3-36) upon subcutaneous administration in male rats.

Authors:  Kelly E Henry; Clinton T Elfers; Rachael M Burke; Oleg G Chepurny; George G Holz; James E Blevins; Christian L Roth; Robert P Doyle
Journal:  Endocrinology       Date:  2015-02-06       Impact factor: 4.736

8.  Uptake and transport of B12-conjugated nanoparticles in airway epithelium.

Authors:  Robyn Fowler; Driton Vllasaliu; Franco H Falcone; Martin Garnett; Bryan Smith; Helen Horsley; Cameron Alexander; Snow Stolnik
Journal:  J Control Release       Date:  2013-09-02       Impact factor: 9.776

Review 9.  Nanoparticle based insulin delivery system: the next generation efficient therapy for Type 1 diabetes.

Authors:  Garima Sharma; Ashish Ranjan Sharma; Ju-Suk Nam; George Priya C Doss; Sang-Soo Lee; Chiranjib Chakraborty
Journal:  J Nanobiotechnology       Date:  2015-10-24       Impact factor: 10.435

Review 10.  Designing the new generation of intelligent biocompatible carriers for protein and peptide delivery.

Authors:  Angela M Wagner; Margaret P Gran; Nicholas A Peppas
Journal:  Acta Pharm Sin B       Date:  2018-03-02       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.